Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Dopamine-Mediated Social Reward Sensitivity to Remediate Social Disconnection

NCT06269146 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT06269146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06269146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Dopamine-Mediated Social Reward Sensitivity to Remediate Social Disconnection
Lead sponsor
University of California, San Diego
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 13, 2024
Completion date
March 31, 2027
Enrollment
108 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, anxiety disorders, depression, social disconnection